Rheumatoid Arthritis
8 months 2 weeks ago
Mechanistic Promise in RA Doesn’t Always Mean Actual Gain
Dr. David Liew reports on abstracts OP0007 and OP0069 at Eular 2024 in Vienna, Austria.
https://t.co/PcKtezJLCH https://t.co/N9tdgFN7Xq
8 months 2 weeks ago
Dual seropositivity and shared epitopes in RA: friends or foes?
Dual seropositivity, RF and/or anti-citrullinated protein antibodies (ACPA) as well as shared epitope (SE) are known to be associated with poor prognosis and structural damage in RA.
https://t.co/QcTHpgPV2Q https://t.co/TzueMr8M5T
It is almost four years since EULAR published its definition of difficult-to-treat (D2T) rheumatoid arthritis (RA) (1). This marked a formal recognition of the group of patients who, despite the…
8 months 2 weeks ago
EULAR 2024: New drugs for RA?
Abiprubart is an Abatacept distant relative, targeting T cell activation through a different target/molecular interaction (CD40/CD154).
https://t.co/3wAGjfCdcN https://t.co/2YK2OeIVZK
8 months 2 weeks ago
How many #autoantibodies
Does one need in
#rheumatoid #arthritis
Need 4 citrullinated peptides
Covers off
97% of IgG CVP2 ACPAs
#EULAR2024 @RheumNow @eular_org https://t.co/LNFGuFXGrC
8 months 2 weeks ago
#EULAR2024 POS0467 - Periodontal disease related tot he development of #RA
ACPA positive and negative pts.
Tooth extraction in CCP positive pts was associated.
Need tooth history in RA. @RheumNow https://t.co/b9Nb3cd0kd
8 months 2 weeks ago
Could dogs smell RA? lol...!
Exhaled breath experimental study to diagnose RA?
Volatile organic compounds can detect RA?
#EULAR2024 @RheumNow https://t.co/FiHsZ522In
Poster Hall